NanoMicrobe introduces new nanotechnology for Microbes. With our technology, we can treat multidrug-resistant microbial infections.
One of them main objective of NanoMicrobe is to create alternative to antibiotics use in farm animals. We have developed a range of products that will be used as growth promoters in poultry industry. Please contact us to seek partnering opportunity.
Our innovative technology by pass microbial resistance pathways and mediates effective microbicidal properties.
Indiscriminate and inappropriate use of antibiotics in human and veterinary medicine has led to the emergence of multidrug resistance (MDR). Bacteria have evolved several strategies to resist antibiotics, including cell wall barrier changes, efflux pumps, target site modifications, and the expression of enzymes that inactivate drugs. There is an increasing trend of MDR infections across the globe and collective efforts to develop alternative biocompatible antimicrobials for clinical use in need. At Nanomicrobe, scientists have developed a new class of cationic antimicrobial molecules that are not described earlier. Our antimicrobial molecules can be used to treat wide variety of microbial infections (including bacterial and fungal infections).